BAC vs GMAB Stock Comparison

GMAB currently leads BAC in this stock comparison, with AIQ scores of 77 vs 58. The clearest difference is momentum, while BAC has the stronger risk resilience profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 19 points
BAC
Financial Services
vs
GMAB
Healthcare
BAC
Bank of America Corporation
Price
$51.02
Day move
+1.01%
AIQ Score
58/100
Best edge
Risk Resilience
Sector
Financial Services
GMAB
Genmab A/S
Leads
Price
$51.37
Day move
-0.72%
AIQ Score
77/100
Best edge
Momentum
Sector
Healthcare

What is the main difference between BAC and GMAB?

GMAB leads the current stock comparison as Genmab A/S, with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Bank of America Corporation vs Genmab A/S

Data as of Nov 15, 2026· market close· Cross-sector · Financial Services vs Healthcare· Coverage 65/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 7/10

GMAB leads

GMAB leads by 19 AIQ points, primarily on Momentum and Quality, and the lead has widened from 15 points over 30 sessions. Wall Street currently favors BAC on target upside.

Competitive: 3 of 6 evidence groups support GMAB, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 3 of 6Comparison trend: Strengthening
BAC

Bank of America Corporation

AIQ Score
58/100
AIQ Edge Score
6/10
GMAB

Genmab A/S

Leads
AIQ Score
77/100
AIQ Edge Score
10/10

The Algovestiq AIQ Score currently favors GMAB over BAC, 77 versus 58 as of Nov 15, 2026. GMAB's advantage is driven primarily by stronger momentum and quality, while BAC holds the stronger risk resilience profile. GMAB also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors BAC. 3 of 6 covered evidence groups favor GMAB today, and the comparison is rated Competitive on stability: only 3 of 6 covered evidence groups agree. GMAB lead: Strengthening — the AIQ differential moved from 15 to 19 points over 30 sessions.

Compare Bank of America Corporation and Genmab A/S across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

BAC
+24.0%
GMAB
+20.6%

Total return comparison

Growth of $10,000, distributions reinvested

BAC $12,399 · GMAB $12,062

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare BAC and GMAB against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

BAC advantage
0
GMAB advantage
  • Momentum37 vs 94
    GMAB +57
  • Risk Resilience83 vs 58
    BAC +25
  • Quality64 vs 72
    GMAB +8
  • Value68 vs 71
    Even

3 of 6 evidence groups favor GMAB. GMAB’s edge is concentrated in momentum and quality; BAC keeps a meaningful risk resilience edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

BAC0 AIQ

No factor moved materially.

New signals

  • OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
GMAB-1 AIQ

No factor moved materially.

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.57x)

GMAB's lead narrowed by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — BAC and GMAB both carry a full feed there.

The central trade-off

GMAB (Genmab A/S): the stronger current systematic profile, led by momentum and quality.

BAC (Bank of America Corporation): the counter-case, on risk resilience, analyst expectations.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

GMAB

GMAB on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

GMAB

GMAB on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

GMAB

GMAB on the Momentum factor, by 57 points.

Lower downside

BAC

BAC on Risk Resilience, by 25 points.

Analyst upside

BAC

BAC on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors GMAB, analyst targets favor BAC. That disagreement is the most useful thing on this page.

MeasureBACGMABNote
Implied upside to target+24.1%+8%BAC has more room
Target dispersion+25.3%+50.5%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering2513Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 6 covered evidence groups favor GMAB. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreGMAB58 vs 77
FundamentalsGMABrevenue growth -3.3% vs 2.8%; EPS growth -23.8% vs 14.3%; TTM ROE 2.3% vs 5.4%; gross margin 60.4% vs 92.6%; operating margin 22.4% vs 30.5%
ValuationEvenValue 68 vs 71
TechnicalsGMABPrice vs 50-day -5.6% vs 24.8%; vs 200-day -7% vs 62.9%
Risk ResilienceBACRisk Resilience 83 vs 58
Analyst expectationsBACTarget upside 24.1% vs 8%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BAC and GMAB and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 19 points. (supports the conclusion holding)
  • Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on GMAB.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

GMAB lead: Strengthening — the AIQ differential moved from 15 to 19 points over 30 sessions.

May 27BAC leads above the line · GMAB leads belowNov 13
Today
GMAB +19
58 vs 77
7 sessions ago
GMAB +21
58 vs 79
30 sessions ago
GMAB +15
62 vs 77
90 sessions ago
BAC +3
71 vs 68

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

BACConflicted

2 bullish / 2 bearish / 1 neutral, conflicted

Only BAC

  • Bollinger Band Squeeze — neutral, volatility, short horizon (4.5%)
  • Death Cross Active — bearish, trend, long horizon (1.45%)
  • Downtrend Structure Active — bearish, trend, long horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
GMABConflicted

3 bullish / 3 bearish / 1 neutral, conflicted

Only GMAB

  • Golden Cross Active — bullish, trend, long horizon (30.48%)
  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (4.51%)
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.57x)
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon
  • RSI Bearish Divergence — bearish, momentum, medium horizon
  • Uptrend Structure Active — bullish, trend, long horizon

GMAB leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

BACNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.01%, AIQ 0 points).

GMABConfirmed weakness

Price and the AIQ Score both moved down over the latest session (price -0.72%, AIQ -1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1BAC closes the Momentum gap — currently 57 points behind, the largest single contributor to GMAB's edge.
  2. 2BAC's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3GMAB's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

GMAB leads on balance
MetricBACGMAB
Revenue growth (YoY)-3.3%2.8%
EPS growth (YoY)-23.8%14.3%
Gross margin60.4%92.6%
Operating margin22.4%30.5%
Return on equity (TTM)2.3%5.4%
Debt to equity1.280.82

Performance

GMAB leads 5 of 6 windows
MetricBACGMAB
1 week (5 sessions)3.2%-4.2%
1 month (20 sessions)-0.4%38.8%
3 months (63 sessions)-20.1%56.4%
6 months (126 sessions)2.5%93.6%
Year to date-7.2%66.8%
1 year (252 sessions)-5.7%68.6%

Technicals

GMAB has the stronger structure
MetricBACGMAB
RSI (14)45.959.1
ADX (14)27.245.8
Price vs 50-day-5.6%24.8%
Price vs 200-day-7%62.9%
Volatility (1M, annualized)24.8%110.9%

Risk

BAC is the more resilient
MetricBACGMAB
Beta0.790.93
Sharpe ratio-0.221.29
Sortino ratio-0.292.53
Max drawdown-23.7%-32.5%
Current drawdown-21.3%-10.3%
Annualized volatility22.4%45.9%
Value at risk (95%)-2.6%-3.2%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, BAC or GMAB?

On the Algovestiq AIQ Score, GMAB is the stronger of the two as of Nov 15, 2026, scoring 77 against BAC's 58. The edge comes from momentum and quality. BAC is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is BAC or GMAB the better buy right now?

GMAB carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 3 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor GMAB over BAC?

The composite weights Quality, Value, Momentum and Risk Resilience. GMAB leads Momentum by 57 points; BAC leads Risk Resilience by 25 points; GMAB leads Quality by 8 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, BAC or GMAB?

Analyst price targets imply +24.1% upside for BAC and +8% for GMAB, so the Street currently favors BAC. That points the opposite way to the AIQ Score, which favors GMAB. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, BAC or GMAB?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, BAC or GMAB?

GMAB on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, BAC or GMAB?

GMAB on the Momentum factor, by 57 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, BAC or GMAB?

BAC is the more resilient of the two, so the other name carries the higher downside risk. BAC on Risk Resilience, by 25 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is BAC more profitable than GMAB?

GMAB leads on the comparable margin measures — gross margin 60.4% vs 92.6%; operating margin 22.4% vs 30.5%; ttm roe 2.3% vs 5.4%.

Is GMAB's lead over BAC getting stronger or weaker?

GMAB lead: Strengthening — the AIQ differential moved from 15 to 19 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the BAC vs GMAB verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BAC closes the Momentum gap — currently 57 points behind, the largest single contributor to GMAB's edge; BAC's Death Cross Active resolves — a bearish trend rule currently active against it; GMAB's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about BAC and GMAB?

BAC: 2 bullish / 2 bearish / 1 neutral, conflicted. GMAB: 3 bullish / 3 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BAC is Death Cross Active (bearish, long horizon). On GMAB it is Golden Cross Active (bullish, long horizon).

Compare BAC and GMAB with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.